Prime-boost immunization generates a high frequency, high-avidity CD8(+) cytotoxic T lymphocyte population (Q47573209)

4 February 2018

title

Prime-boost immunization generates a high frequency, high-avidity CD8(+) cytotoxic T lymphocyte population (English)

1 reference

4 February 2018

0 references

0 references

0 references

Marie J Estcourt

1

1 reference

4 February 2018

Alistair J Ramsay

2

1 reference

4 February 2018

Andrew Brooks

3

1 reference

4 February 2018

Scott A Thomson

4

1 reference

4 February 2018

Coralie J Medveckzy

5

1 reference

4 February 2018

Ian A Ramshaw

6

1 reference

4 February 2018

publication date

1 January 2002

1 reference

4 February 2018

published in

International Immunology

1 reference

4 February 2018

volume

14

1 reference

4 February 2018

issue

1

1 reference

4 February 2018

page(s)

31-37

1 reference

4 February 2018

DNA vaccines: immunology, application, and optimization*

cites work

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.31

Cytokines and immunity to viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.31

Genetic vaccination strategies for enhanced cellular, humoral and mucosal immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.31

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.31

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.31

The prime-boost strategy: exciting prospects for improved vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.31

Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.31

Phenotypic analysis of antigen-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.31

Evolution of a complex T cell receptor repertoire during primary and recall bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.31

A kinetic basis for T cell receptor repertoire selection during an immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.31

Herpes simplex virus type 1-specific cytotoxic T-lymphocyte arming occurs within lymph nodes draining the site of cutaneous infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.31

T lymphocyte responses in HIV-1 infection: implications for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.31

High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.31

T cell affinity maturation by selective expansion during infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.31

An inverse relationship between T cell receptor affinity and antigen dose during CD4(+) T cell responses in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.31

Differential expansion and survival of high and low avidity cytotoxic T cell populations during the immune response to a viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINTIMM%2F14.1.31

21 January 2018

Identifiers

DOI

10.1093/INTIMM/14.1.31

1 reference

4 February 2018

PubMed ID

11751749

1 reference

4 February 2018